Beta-Defensin-1 vs Ramoplanin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Human beta-defensin-1 (HBD-1) is a constitutively expressed antimicrobial peptide produced by epithelial cells of the skin, respiratory tract, and genitourinary system. Unlike inducible defensins, HBD-1 is present at steady-state levels as a component of basal innate immune defen...
Calculate Beta-Defensin-1 dose →Ramoplanin is a glycodepsipeptide antibiotic produced by Actinoplanes sp. ATCC 33076 with potent activity against gram-positive bacteria....
Calculate Ramoplanin dose →| Parameter | Beta-Defensin-1 | Ramoplanin |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Preclinical | Phase 3 (Discontinued) |
| Half-Life | Hours | Short (gut lumen) |
| Typical Dose | N/A (endogenous) | 200 mg twice daily |
| Frequency | Constitutive | Twice daily |
| Route | Endogenous | Oral (non-absorbed) |
| FDA Status | Not approved | Not approved (Phase 3 discontinued) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.